An uplift to £9.1m in the investment value of its stake in NuCana plc, the NASDAQ-quoted Edinburgh-headquartered business whose ProTide technology transforms some of the most widely prescribed chemotherapy treatments
Why? Free to subscribe, no paywall, daily business news digest.